000 | 01879 a2200553 4500 | ||
---|---|---|---|
005 | 20250518003757.0 | ||
264 | 0 | _c20190228 | |
008 | 201902s 0 0 eng d | ||
022 | _a1784-3227 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYuksel, I | |
245 | 0 | 0 |
_aIncreasing challenges of inflammatory bowel disease in a Turkish cohort (2006-2016). _h[electronic resource] |
260 |
_bActa gastro-enterologica Belgica _c |
||
300 |
_a373-380 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdalimumab _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
650 | 0 | 4 |
_aCigarette Smoking _xepidemiology |
650 | 0 | 4 |
_aColitis, Ulcerative _xepidemiology |
650 | 0 | 4 |
_aCrohn Disease _xepidemiology |
650 | 0 | 4 |
_aDigestive System Surgical Procedures _xtrends |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
650 | 0 | 4 |
_aHospitalization _xtrends |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xepidemiology |
650 | 0 | 4 |
_aInfliximab _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesalamine _xtherapeutic use |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSex Distribution |
650 | 0 | 4 |
_aSulfasalazine _xtherapeutic use |
650 | 0 | 4 |
_aTurkey _xepidemiology |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aKilincalp, S | |
700 | 1 | _aCoşkun, Y | |
700 | 1 | _aAkinci, H | |
700 | 1 | _aKaraahmet, F | |
700 | 1 | _aHamamci, M | |
773 | 0 |
_tActa gastro-enterologica Belgica _gvol. 81 _gno. 3 _gp. 373-380 |
|
999 |
_c28968006 _d28968006 |